SARDH and neoplasm: Similarly, we observed markedly slower tumor growth in mice with T-cell-specific knockout of SARDH (Lck-CRE, SARDHF/F, OT-1+; CKO) than in WT mice (Fig. 4C; Supplementary Fig. S7A‒C).